Arovella Therapeutics Ltd (ala) Logo

Arovella Therapeutics Ltd (ALA)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News

ALA ASX Chart

Snapshot

Arovella Therapeutics Limited (ALA, formerly Suda Pharmaceuticals Ltd) is a biotechnology company focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumours. Arovella's product is ALA-101. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +85.91%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 730 of 2,357
Sector Rank 55 of 230

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies DXB / PAR / CGS
EPS -$0.009
DPS $0.00
Book Value Per Share $0.011

Broker Consensus

ALA is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Osborne Park WA 6017
Website www.arovella.com
Registry Automic Group
Auditor HLB Mann Judd (WA Partnership)
Date Listed 24 Jan 2002

Upcoming Calendar (Forecasted)

Date Event
26/02/2025 Report (Interim)
21/08/2025 Report (Prelim)
21/08/2025 Report (Annual)

Former Company Names

  • Suda Pharmaceuticals Ltd (SUD ), 22/10/2021
  • Suda Ltd (SUD), 04/12/2017
  • Eastland Medical Systems Ltd (EMS), 06/12/2012

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

ALA directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
26/11/24 Thomas (Tom) Duthy Issued 620,000 $0.185 $114,700 Director remuneration
26/11/24 Michael Baker Issued 1,658,483 $0.185 $306,819 Director remuneration
26/11/24 Elizabeth Stoner Issued 354,000 $0.185 $65,490 Director remuneration
26/11/24 Gary Phillips Issued 354,000 $0.185 $65,490 Director remuneration
26/11/24 Debora Barton Issued 354,000 $0.185 $65,490 Director remuneration
28/03/24 Gary Phillips Buy +66,666 $0.15 $10,000 On-market trade
28/03/24 Thomas (Tom) Duthy Buy +103,000 $0.145 $14,935 On-market trade
27/03/24 Michael Baker Buy +220,000 $0.142 $31,289 On-market trade
29/12/23 Michael Baker Buy +587,824 $0.115 $67,599 Exercise of options
29/12/23 Michael Baker Exercise 2,800,000 $0.115 $322,000 Exercise of options
04/12/23 Thomas (Tom) Duthy Issued 319,000 $0.088 $28,072 Director remuneration
04/12/23 Michael Baker Issued 2,178,531 $0.088 $191,710 Issue of options
04/12/23 Elizabeth Stoner Issued 618,000 $0.088 $54,384 Director remuneration
04/12/23 Gary Phillips Issued 618,000 $0.088 $54,384 Director remuneration
04/12/23 Debora Barton Issued 618,000 $0.088 $54,384 Director remuneration
24/08/23 Thomas (Tom) Duthy Issued 6,521,739 $0.046 $299,999 Issue of options
24/08/23 Thomas (Tom) Duthy Issued 2,250,000 $0.046 $103,500 Issue of securities
12/07/23 Gary Phillips Issued 222,222 $0.045 $9,999 Participation in share purchase plan
12/07/23 Michael Baker Issued 666,666 $0.045 $29,999 Participation in share purchase plan
12/07/23 Thomas (Tom) Duthy Issued 444,444 $0.045 $19,999 Participation in share purchase plan
05/05/23 Gary Phillips Issued 500,000 $0.02 $10,000 Placement
05/05/23 Michael Baker Issued 1,250,000 $0.02 $25,000 Placement
05/05/23 Elizabeth Stoner Issued 500,000 $0.02 $10,000 Placement
15/12/22 Gary Phillips Issued 1,600,000 $0.025 $40,000 Director remuneration
15/12/22 David Simmonds Issued 1,600,000 $0.025 $40,000 Director remuneration
15/12/22 Debora Barton Issued 2,400,000 $0.025 $60,000 Director remuneration
15/12/22 Elizabeth Stoner Issued 4,800,000 $0.025 $120,000 Director remuneration
02/12/22 Michael Baker Issued 1,586,842 $0.038 $60,299 Director remuneration
16/03/22 Elizabeth Stoner Issued 263,157 $0.038 $9,999 Placement
16/03/22 Debora Barton Issued 263,157 $0.038 $9,999 Placement
16/03/22 David Simmonds Issued 263,157 $0.038 $9,999 Placement
16/03/22 Michael Baker Issued 789,473 $0.038 $29,999 Placement
16/03/22 Paul Hopper Issued 3,263,156 $0.038 $123,999 Placement
16/03/22 Paul Hopper Issued 631,578 $0.038 $23,999 Placement
16/12/21 Elizabeth Stoner Issued 2,400,000 $0.04 $96,000 Issue of options
16/12/21 Debora Barton Issued 2,400,000 $0.04 $96,000 Issue of options
16/12/21 Paul Hopper Issued 6,000,000 $0.04 $240,000 Issue of options
15/12/21 Michael Baker Buy +650,000 $0.039 $25,350 On-market trade
15/12/21 Paul Hopper Buy +1,000,000 $0.04 $40,000 On-market trade
11/11/21 Michael Baker Issued 8,000,000 $0.041 $328,000 Issued under employee share plan
Show All

Director Interests

The current holdings of ALA directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Elizabeth Stoner 26/11/2024 763,157 N/A 8,172,000 N/A
Debora Barton 26/11/2024 263,157 N/A 5,772,000 N/A
Michael Baker 26/11/2024 0 6,567,472 11,837,014 N/A
Thomas (Tom) Duthy 26/11/2024 N/A 4,747,444 7,460,736 N/A
Gary Phillips 26/11/2024 0 788,888 2,572,000 N/A
David Simmonds 15/12/2022 513,157 N/A 1,600,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 5, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
The Trust Company (Australia) Limited Mbf A/C 59,019,000 5.62%
MB Investment Capital Pty Ltd 27,749,415 2.64%
UBS Nominees Pty Ltd 25,620,196 2.44%
Mr James Evan Hughes-Morris 21,917,196 2.09%
Blackburne Capital Pty Ltd Blackburne Capital A/C 20,695,706 1.97%
Mann Beef Pty Ltd 20,000,000 1.90%
Mann Beef Pty Ltd i 19,555,555 1.86%
DP Investment Capital Pty Ltd 18,000,000 1.71%
Dylide Pty Ltd 17,166,666 1.63%
TK Cooper Holdings Pty Ltd 15,186,620 1.45%
M & M Stock One Pty Ltd The M & M Stock One A/C 13,596,581 1.29%
Mr Neil Donald Delroy The Ndd Investment A/C 13,067,222 1.24%
Ajava Holdings Pty Ltd 12,543,194 1.19%
Murray James Way Pty Ltd 12,022,400 1.14%
Mann Beef Pty Ltd Lochwall Super Fund A/C 11,350,102 1.08%
Mrs Naomi Hughes Morris 11,309,868 1.08%
Moovnup Pty Ltd Moovnup A/C 11,067,962 1.05%
Widerange Corporation Pty Ltd 10,390,789 0.99%
Mr Richard John Mann 10,000,000 0.95%
Mr Brendan John Martin & Mrs Sharon Ann Martin Jaknic Super A/C 9,564,970 0.91%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 703 734 580 2,013 929 4,959

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Merchant Funds Management Pty Ltd 13/09/2024 60,496,667 5.75
Biotech Capital Management Pty Ltd 13/09/2024 108,836,842 10.35

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
13-09-24 Biotech Capital Management Pty Ltd 108,836,842 -- 10.35

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
13-09-24 Merchant Funds Management Pty Ltd 25,713,615 11.4 5.75

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.14 28 June
2023 $0.05 30 June
2022 $0.023 30 June
2021 $0.057 30 June
2020 $0.037 30 June
2019 $0.003 28 June
2018 $0.008 29 June
2017 $0.019 30 June
2016 $0.02 30 June
2015 $0.028 30 June
2014 $0.05 30 June
ALA Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.